Laura G. Eichorn
Founder presso IMAGO BIOSCIENCES, INC.
Posizioni attive di Laura G. Eichorn
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| IMAGO BIOSCIENCES, INC. | Founder | 01/03/2012 | - |
| Director of Finance/CFO | - | - | |
| Chief Operating Officer | - | 24/03/2022 |
Storia della carriera di Laura G. Eichorn
Precedenti posizioni note di Laura G. Eichorn
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
FerroKin BioSciences, Inc.
 FerroKin BioSciences, Inc. Pharmaceuticals: MajorHealth Technology FerroKin BioSciences, Inc. offers clinical stage biotechnology services for iron chelator in the treatment of iron-overload in patients with transfusion-dependent hereditary and acquired refractory anemia. The company was founded by Hugh Young Rienhoff, Jr. in 2007 and is headquartered in San Carlos, CA. | Chief Operating Officer | 01/01/2007 | - |
| Director of Finance/CFO | 01/01/2007 | - | |
| Corporate Officer/Principal | - | - |
Formazione di Laura G. Eichorn
| Frostburg State University | Undergraduate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 4 |
Posizioni
| Chief Operating Officer | 2 |
| Director of Finance/CFO | 2 |
| Corporate Officer/Principal | 1 |
Settori
| Health Technology | 3 |
| Consumer Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Aziende private | 2 |
|---|---|
FerroKin BioSciences, Inc.
FerroKin BioSciences, Inc. Pharmaceuticals: MajorHealth Technology FerroKin BioSciences, Inc. offers clinical stage biotechnology services for iron chelator in the treatment of iron-overload in patients with transfusion-dependent hereditary and acquired refractory anemia. The company was founded by Hugh Young Rienhoff, Jr. in 2007 and is headquartered in San Carlos, CA. | Health Technology |
Imago BioSciences, Inc.
 Imago BioSciences, Inc. BiotechnologyHealth Technology Imago BioSciences, Inc. operates as a clinical-stage biopharmaceutical company that develops novel anti-cancer therapeutics. It translates science of genetics and epigenetics enzymes into novel medicines for treating myeloid diseases that pose challenges to patients, families, and physicians. The company also translates insights into transformative therapies that alter the history of disease allowing patients to live longer and disease-free lives. Imago BioSciences was founded by Hugh Young Rienhoff, Jr., Laura G. Eichorn and Jennifer Peppe on March 29, 2012 and is headquartered in Redwood City, CA. | Health Technology |
- Borsa valori
- Insiders
- Laura G. Eichorn
- Esperienza
